This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun 20;317(23):2452.

doi: 10.1001/jama.2017.5967.

Nonreproducibility of Preclinical Research

Peter G Goldschmidt¹

Affiliations

PMID: 28632858
DOI: 10.1001/jama.2017.5967

Comment

Nonreproducibility of Preclinical Research

Peter G Goldschmidt. JAMA. 2017.

. 2017 Jun 20;317(23):2452.

doi: 10.1001/jama.2017.5967.

Author

Peter G Goldschmidt¹

Affiliation

¹ World Development Group Inc, Bethesda, Maryland.

PMID: 28632858
DOI: 10.1001/jama.2017.5967

No abstract available

PubMed Disclaimer

Comment in

Nonreproducibility of Preclinical Research-Reply.
Ioannidis JPA. Ioannidis JPA. JAMA. 2017 Jun 20;317(23):2453. doi: 10.1001/jama.2017.5987. JAMA. 2017. PMID: 28632861 No abstract available.

Comment on

Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research.
Ioannidis JP. Ioannidis JP. JAMA. 2017 Mar 14;317(10):1019-1020. doi: 10.1001/jama.2017.0549. JAMA. 2017. PMID: 28192565 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations